- Associated Press•12 days ago
On a per-share basis, the Toronto-based company said it had a loss of 8 cents. The extended-release drug developer posted revenue of $556,000 in the period. The company's shares closed at $1.62. A year ...
- Insider Monkey•18 days ago
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) is a tiny Canadian biotech with no approved products and a market capitalization of a little over $40 million at last count. It generates virtually no revenues, and its entire cash holding derives from a $5.2 million public offering that closed at the beginning of last month. It’s down close to […]
IntelliPharmaCeutics International Inc.NasdaqCM
|Bid||1.60 x 5900|
|Ask||1.62 x 300|
|52wk Range||1.41 - 3.61|
|Day's Range||1.60 - 1.64|
|Avg Vol (3m)||118,409|
As of 1:44 PM EDT. NasdaqCM Real Time Price. Market open.